FluidForm Bio™ Announces Participation in Venture Summit West
WALTHAM, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that Mike Graffeo, CEO and co-founder, will deliver a company overview and conduct one-on-one meetings at Venture Summit West, which is being held April 2-3 in Mountain View, CA.
Details of the presentation are as follows:
Session:
Round II – Life Sciences/Healthcare
Date:
April 3, 2025
Time:
11:40am PT (2:40pm ET)
In addition to a corporate update, FluidForm will share data on its lead program in islet cell replacement therapy. A critical factor for the success of islet cell replacement therapy is the promotion of vascularization to support rapid engraftment and promote long-term cell viability. The data demonstrate that this approach drives rapid vascularization throughout the tissue, ensuring that islets receive adequate blood supply, which is essential for long-term cell survival and function. By reducing early islet loss, the therapy will be more durable, eliminating the need for supplemental infusions that are often required with other methods. This durability is expected to translate into a more stable and long-term treatment for patients, reducing the frequency of medical interventions and improving the quality of life.
Registrants can request one-on-one meetings with FluidForm management, and more information about the Summit can be found at the following link: https://youngstartup.com/events/vsw25/
About FluidForm Bio™ FluidForm Bio™ is a biotechnology company developing next-generation cell therapies for chronic diseases leveraging its proprietary FRESH™ 3D bioprinting technology platform. Using FRESH, FluidForm creates functional tissue with the same materials found in the human body, eliminating chemistries and materials known to trigger negative immune response. FRESH is a powerful vascularization platform, allowing the building of densely cellular vascularized tissue that maintains viability upon implant.
The company's lead program is an islet cell therapy for type 1 diabetes in which insulin-producing beta cells are arranged in a tissue scaffold ready for subcutaneous implantation. This method is less invasive and less toxic when compared to other delivery sites, offering retrievability and reducing surgical risks and recovery time for patients.
This novel approach to islet cell replacement therapy presents a transformative advancement in diabetes treatment. With superior fabrication techniques, enhanced vascularization, a robust immune modulation platform, and a convenient subcutaneous implant, this method addresses many limitations of current technologies. These improvements offer the potential for a more effective, durable, and patient-friendly therapy, offering new hope for individuals with diabetes.
Founded in 2018, FluidForm is headquartered in Waltham, MA. To learn more, please visit: fluidformbio.com or connect on Twitter and LinkedIn.
Contact:Corey Davis, Ph.D.LifeSci Advisors+1 212 915 2577cdavis@lifesciadvisors.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
South Africa Employee Benefits 2025: Comprehensive Overview of State and Private Employee Benefits in South Africa
Unlock comprehensive insights into South Africa's employee benefits landscape with this in-depth report. Explore state, compulsory, and private benefits, understand regulatory frameworks, and discover the roles of key institutions. Ideal for strategic decision-making and understanding South Africa's social security system. Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "Employee Benefits in South Africa 2025" report has been added to report provides in-depth industry analysis, information, and insights of the employee benefits in South Africa, including an overview of the state and compulsory benefits in South Africa, detailed information about the private benefits in South Africa, insights on various central institutions responsible for the administration of the different branches of social security and the regulatory framework of the employee benefits in South Africa has a well-developed social security system, which covers employees and their dependents, as well as unemployed persons and individuals. The Department of Labor (DoL) is the central labor administration body and is regulated by the Ministry of Labor. The South African social security system is composed of three pillars: the non-contributory pillar (taxed pillar), the contributory pillar, and the private voluntary pillar. The contributory pillar includes social insurance, while the non-contributory pillar includes social assistance and social relief distress. The private voluntary pillar covers pensions, short-term, work-injury, and healthcare benefits and is usually voluntary, but can become obligatory based on a company's policy, work, industry, and Highlights South African Social Security Agency, Financial Sector Conduct Authority and Department of Labor are responsible for the functioning of the overall social security system in South Africa. A person's national insurance contribution is determined based on their income. An insured person who is unemployed or unable to work and whose benefits have been exhausted is entitled to credited contribution. In South Africa, employers provide supplementary pension benefits as social security benefits. This report provides a detailed analysis of employee benefits in South Africa It offers a detailed analysis of the key government-sponsored employee benefits, along with private benefits It covers an exhaustive list of employee benefits, including retirement benefits, death in Service, Short-term Sickness Benefit, medical benefits, workmen's compensation insurance, maternity and paternity benefits, unemployment benefit, Family Benefit, Grant-in-Aid, Social Relief distress, leaves and holidays and private benefits It highlights the economic and regulatory situations relating to employee benefits in South Africa Reasons to Buy Make strategic decisions using in-depth information related to employee benefits in the country Assess employee benefits of the market, including state and compulsory benefits and private benefits Gain insights into the key employee benefit schemes offered by private employers in the country Gain insights into key organizations governing employee benefits market, and their impact on companies Key Topics Covered: 1. Executive Summary2. Introduction3. Country Statistics4. Overview of Employee Benefits in South Africa5. Regulations6. State and Compulsory Benefits6.1 Retirement Benefits Introduction Eligibility Benefits Payment options Contribution 6.2 Death in Service Introduction Eligibility Benefits Payment options Contribution 6.3 Long-Term Disability Benefits Introduction Eligibility Benefits Payment options Contribution 6.4 Short-Term Disability Benefits Introduction Eligibility Benefits Payment options Contribution 6.5 Medical Benefits Introduction Eligibility Benefits Payment options Contribution 6.6 Workers' Compensation insurance Introduction Eligibility Benefits Payment options Contribution 6.7 Maternity and Paternity Benefits Introduction Eligibility Benefits Payment options Contribution 6.8 Other Benefits Unemployment Benefit Family Benefits Grant in Aid Social Relief distress Leaves and Holidays 7. Private Benefits7.1 Retirement Benefits7.2 Death Benefits7.3 Disability Benefits7.4 Medical Benefits7.5 Accidental Death and Dismemberment Benefits7.6 Other BenefitsFor more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
16 minutes ago
- Yahoo
High Throughput Process Development Strategic Business Report 2025-2030: Increasing Focus on Speed and Efficiency in Drug Discovery Expands Market Opportunities
The global High Throughput Process Development (HTPD) market, pivotal for the biopharmaceutical industry, is projected to grow from $15.3 billion in 2024 to $24.6 billion by 2030, at a CAGR of 8.3%. Key drivers include technological innovations in automation and data analytics. The market is segmented by product types, including consumables and software, with major growth forecasted in regions such as China and the U.S. The report offers insights into market trends, regional analysis, and profiles leading companies like Agilent Technologies and Danaher Corporation. High Throughput Process Development Market Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "High Throughput Process Development - Global Strategic Business Report" report has been added to global market for High Throughput Process Development was valued at US$15.3 Billion in 2024 and is projected to reach US$24.6 Billion by 2030, growing at a CAGR of 8.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the High Throughput Process Development market. The growth in the high throughput process development market is driven by several factors, including the increasing complexity of biologic drugs, the rising demand for personalized medicines, and advancements in automation and data analytics. As the biopharmaceutical industry shifts toward more complex therapeutics, such as gene and cell therapies, the need for efficient process optimization is more critical than ever. HTPD allows companies to streamline the development of these therapies, reducing both time and costs. The growing demand for biosimilars, which require rapid process development to compete with branded biologics, is also contributing to market growth. Additionally, the adoption of automation and machine learning in process development is further enhancing the efficiency and accuracy of bioprocess optimization, driving the market's throughput process development (HTPD) is a critical tool in the biopharmaceutical industry, enabling faster, more efficient development of biologic drugs. HTPD involves the use of automated, miniaturized experiments that allow researchers to test multiple process conditions simultaneously, significantly accelerating the optimization of production processes for therapeutic proteins, vaccines, and monoclonal antibodies. The ability to screen numerous variables at once reduces the time and resources needed to scale up bioprocesses, from lab-scale to commercial manufacturing. As biopharmaceutical companies face increasing pressure to reduce costs and bring therapies to market faster, HTPD has become indispensable in ensuring both process efficiency and product Are Technological Innovations Shaping High Throughput Process Development?Technological innovations, particularly in automation, robotics, and data analytics, have revolutionized high throughput process development. Automation systems now allow for the simultaneous running of hundreds of experiments, enabling researchers to optimize cell culture conditions, purification processes, and formulation strategies more efficiently. The integration of advanced data analytics and machine learning into HTPD platforms has further enhanced process optimization, allowing for predictive modeling and real-time decision-making. Microfluidic technologies, which allow for the precise control of small volumes of liquids, are also playing a critical role in reducing reagent use and increasing the speed of bioprocess optimization. These technologies are enabling biopharmaceutical companies to streamline their development timelines and reduce production Do Market Segments Define the Growth of the High Throughput Process Development Market?Product types include consumables, software, and instruments, with consumables like reagents and microplates holding the largest market share due to their constant need in HTPD workflows. Services such as contract research and process development outsourcing are also expanding, as biopharmaceutical companies increasingly seek external expertise to accelerate drug development. The biopharmaceutical industry, particularly companies focused on biologics such as monoclonal antibodies, is the primary end-user of HTPD, as it enables rapid scale-up from R&D to manufacturing. Other key users include academic and research institutes involved in biotechnology Scope Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as Agilent Technologies, Aurora Biomed, Axxam S.P.A., Bio-Rad Laboratories, Danaher Corporation and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. Key Insights: Market Growth: Understand the significant growth trajectory of the Monoclonal Antibodies segment, which is expected to reach US$17.8 Billion by 2030 with a CAGR of a 9.1%. The Other Molecule Types segment is also set to grow at 6.5% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, valued at $3.9 Billion in 2024, and China, forecasted to grow at an impressive 12.6% CAGR to reach $6.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Segments Molecule Type (Monoclonal Antibodies, Other Molecule Types) Component (Tools & Systems, Consumables, Software, Other Components) Technology (Chromatography, Ultraviolet-Visible Spectroscopy, Other Technologies) End-Use (Biopharmaceutical Companies, Contract Research Organizations, Academic Research Institutes) Tariff Impact Analysis: Key Insights for 2025What's Included in This Edition: Tariff-adjusted market forecasts by region and segment Analysis of cost and supply chain implications by sourcing and trade exposure Strategic insights into geographic shifts Buyers receive a free July 2025 update with: Finalized tariff impacts and new trade agreement effects Updated projections reflecting global sourcing and cost shifts Expanded country-specific coverage across the industry Key Attributes: Report Attribute Details No. of Pages 89 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $15.3 Billion Forecasted Market Value (USD) by 2030 $24.6 Billion Compound Annual Growth Rate 8.3% Regions Covered Global Key Topics Covered: MARKET OVERVIEW Influencer Market Insights Tariff Impact on Global Supply Chain Patterns Global Economic Update High Throughput Process Development - Global Key Competitors Percentage Market Share in 2024 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E) MARKET TRENDS & DRIVERS Rising Demand for Biopharmaceuticals Drives Growth in High Throughput Process Development Technological Advancements in Automation and Robotics Propel Innovation in High Throughput Process Development Increasing Focus on Speed and Efficiency in Drug Discovery Expands Addressable Market for High Throughput Solutions Growing Adoption of High Throughput Technologies in Vaccine Development Spurs Market Growth Surge in Demand for Personalized Medicine Strengthens Business Case for High Throughput Process Development Increasing Use of High Throughput Screening in Protein and Antibody Discovery Expands Market Potential Technological Innovations in Microfluidics and Lab Automation Propel Market Innovation Growing Focus on Reducing Time-to-Market for Pharmaceuticals Drives Adoption of High Throughput Processes Rising Use of Artificial Intelligence (AI) in High Throughput Data Analysis Strengthens Competitive Advantage Increasing Focus on Process Optimization and Scalability in Biopharmaceutical Production Drives Innovation Rising Demand for High Throughput Analytical Techniques in Quality Control Expands Market Opportunities FOCUS ON SELECT PLAYERS:Some of the 33 companies featured in this report Agilent Technologies Aurora Biomed Axxam S.P.A. Bio-Rad Laboratories Danaher Corporation Eppendorf GE Healthcare Hamilton Company Merck Millipore Perkinelmer Sartorius Stedim Biotech Tecan Group Thermo Fisher Scientific, Inc. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment High Throughput Process Development Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
32 minutes ago
- Yahoo
The Roland Gossage Foundation and Lighthouse Labs to Provide Ontario Veterans with Free, In-Demand Digital Skills Training through Soldiers in Tech
The comprehensive, fully-funded initiative will help veterans transition to civilian life using technology as a bridge to open a new chapter TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Today, the Roland Gossage Foundation, a non-profit organization that strives to improve the lives of military personnel and their families as they transition to civilian life, is announcing the return of Soldiers in Tech. Delivered by the Roland Gossage Foundation in partnership with tech education leader Lighthouse Labs, this program offers a series of comprehensive courses designed to empower members of the military community with the skills and knowledge needed to thrive in today's digital economy. As global security concerns and economic resilience rise to the forefront of Canada's priorities, strengthening the defence sector means more than building equipment—it requires building people. Soldiers in Tech precedes this renewed commitment, having long invested in the upskilling of veterans, reservists, and military families so they can continue contributing to Canada's strength in new ways. Participants can choose from two flexible formats: an intensive 12-week bootcamp or a 30-week Flex program, allowing them to tailor their learning to their schedules. With hands-on training, career services, and mental wellness support, Soldiers in Tech empowers members of the military community to thrive in the digital economy—while continuing to serve the country beyond the uniform. 'The Roland Gossage Foundation is thrilled to bring Soldiers in Tech back for a fifth year,' said Roland Gossage, Founder of the Roland Gossage Foundation. 'Whether you're a veteran transitioning to civilian life, a spouse seeking new career opportunities, or a reservist balancing service with professional growth, our programs are designed to support learners at all levels by combining industry-relevant skills with hands-on experience. We deeply value the transferable skills, experiences, and contributions of military personnel who have served this country, and we're proud to help veterans and their families confidently embark on new career paths in technology and beyond.' Program Details Web Development: Build and maintain digital systems that connect businesses and the tools people use every day. This full-stack program covers modern web technologies used in everything from e-commerce and healthcare platforms to supply chain systems. Cyber Security: Protect the systems that protect our country. Learn to detect, prevent, and respond to cyber threats—skills in high demand across defense, finance, manufacturing, and more. Data Analytics: Make data work for better decisions. This program teaches participants how to turn raw data into insights that guide operations in sectors like energy, logistics, and public services. Data Science: Go beyond analytics into automation and prediction. Learn to build models and uncover patterns that drive innovation in fields like transportation, public health, and engineering. 'As the world undergoes rapid digital transformation, people are turning to the tech sector to find more creative and rewarding career opportunities,' said Jeremy Shaki, CEO of Lighthouse Labs. 'At Lighthouse Labs, we're excited to continue our participation in Soldiers in Tech as the training provider to help veterans acquire new skills, expand their career opportunities, and pursue fulfilling roles in web development, cyber security, data analysis, and data science. By providing accessible training and an abundance of career resources, we're also pleased to bring new talent to Ontario's growing tech sector.'This Employment Ontario program is funded in part by the Government of Canada and the Government of Ontario. Flex Program cohorts begin on June 9, 2025, followed by the next wave of 12-week programs starting on June 23, 2025, with additional courses scheduled throughout July and August 2025. Soldiers in Tech proudly welcomes all post-service Canadian military veterans, as well as the spouses of veterans and reservists. Applicants must reside in Ontario. For more information or to apply, please visit: About the Roland Gossage FoundationAt the Roland Gossage Foundation, our primary focus is on improving the lives of military personnel and their families as they transition to civilian life. We are dedicated to addressing the challenges that veterans face when leaving the military and entering the civilian world. Our two unique programs, Soldiers in Tech and Soldiers in the Arts, are designed to provide veterans with opportunities to pursue new careers in the fields of Cyber Security, Web Development, Data Analytics, Data Science, and the Arts. Through dedicated instruction, wellness support, and career services, we aim to ensure that veterans have the necessary resources and guidance to succeed in their civilian careers and to overcome the difficulties of this transition. For more information, visit About Lighthouse LabsLighthouse Labs, a Uvaro company, is a leading tech education provider that empowers individuals to transform their lives through skills development and career growth. Committed to closing the digital skills gap, it supports equity-deserving groups to ensure technological change becomes an opportunity for all. Now in its 11th year, Lighthouse Labs has trained over 40,000 learners through full-time and part-time programs in cybersecurity, data science, data analytics, web development, and more. For more information, visit Media Contact Logan FindlayTalk Shop Media logan@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
